Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and oritavancin

beta-lactams has been researched along with oritavancin in 3 studies

Compound Research Comparison

Studies
(beta-lactams)		Trials
(beta-lactams)		Recent Studies (post-2010)
(beta-lactams)		Studies
(oritavancin)		Trials
(oritavancin)		Recent Studies (post-2010) (oritavancin)
7,5791793,39524511137

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E1
Raut, A; Rybak, MJ; Smith, JR; Yim, J1
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS1

Other Studies

3 other study(ies) available for beta-lactams and oritavancin

ArticleYear
Antimicrobial development in the era of emerging resistance.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:8

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration

2009
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci

2016
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Staphylococcus aureus

2016